• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Takotsubo syndrome is a condition characterized by acute transient left ventricular systolic
dysfunction, which at presentation can be challenging to distinguish from acute myocardial …

2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

In the late 19th century, postmortem examinations demonstrated a possible relationship
between thrombotic occlusion of a coronary artery and myocardial infarction (MI). 1 …

Takotsubo syndrome (TTS) is a poorly recognized heart disease that was initially regarded
as a benign condition. Recently, it has been shown that TTS may be associated with severe …

The clinical expert consensus statement on takotsubo syndrome (TTS) part II focuses on the
diagnostic workup, outcome, and management. The recommendations are based on …

Peripartum cardiomyopathy (PPCM) is a potentially life‐threatening condition typically
presenting as heart failure with reduced ejection fraction (HFrEF) in the last month of …

Takotsubo syndrome (TTS) has been a recognized clinical entity for 31 years, since its first
description in 1990. TTS is now routinely diagnosed in patients who present with acute chest …